For how we live.
Every article we have published on Non Communicable Diseases, newest first.
A Global Burden of Disease analysis of Kenya's 47 counties found ischaemic stroke killed 11,328 people in 2023 — death rates are falling even as new cases rise, with raised blood pressure behind 35% of the burden.
The first GBD 2023 estimate of heart failure maps not just its size but its causes — and the causes split the world: alcohol in eastern Europe, Chagas disease in Latin America, rheumatic disease in the global south.
A Global Burden of Disease 2023 analysis counts 241 million users worldwide, concentrated in south Asia, with a rising burden of stroke and oral cancer even as prevalence has barely moved.
The PURE study measured airflow obstruction in adults across 25 countries and found most cases had never been labelled, with the largest undiagnosed share in lower-income settings.
A regional Global Burden of Disease analysis attributes 15.8 million healthy life-years lost in 2023 to high body-mass index, and warns of a 346.3% rise in obesity among the young.
The Global Burden of Disease 2023 study estimates 2.33 billion NCD incident cases and 263 million DALYs across Africa, with high blood pressure the single largest driver of the continent's NCD deaths.
A pooled analysis of 315,403 adults finds wealth inequalities in hypertension, diabetes and cholesterol care grow across the care cascade — but the biggest treatment gaps are not where most heart risk could be averted.
A Global Burden of Disease 2023 study counts 1,102,794 incident tracheal, bronchus and lung cancers in Asians aged 60 and over in 2023, with ageing populations set to sustain the burden even as rates fall.
A descriptive study using WHO modelled estimates for 2022 put current cigarette use between 1.7% in Ghana and 18.2% in Seychelles, with the male-female gap reaching 36.4 points in Lesotho.
The dream was 'compression of morbidity' — sickness squeezed into a short window before death. Across 183 countries the healthspan–lifespan gap instead grew to 9.6 years, and to 12.4 in the US.
A WHO data-set analysis shows how mobile and hospital teams split the load of hypertension, diabetes and epilepsy care during the war, while a separate study tracked dialysis capacity falling.
National surveys show risk behaviours climbing among adults with diabetes since 2007, while a separate study finds noncommunicable-disease mortality nearly twice as high in the worst-affected province as in the best.
A prospective study of 660 Syrian refugees living with noncommunicable diseases found symptom burden peaked in the hottest, dustiest period — with asthma and hypertension carrying the highest risk.
Two peer-reviewed studies chart the toll: among 122 Khartoum dialysis patients followed for up to 18 months, 53% survived, and those who stayed in the capital fared worst.
After 12 months, HbA1c was 6.5% among people managed by community health workers versus 7.1% among those referred to clinics. With 103 participants analysed, the confidence interval crosses zero.
Stroke is the world's second-leading cause of death and third-leading cause of disability. The new resolution asks countries to build stroke-ready emergency systems, not just treat risk factors.
Large taxed beverage sales fell 24 to 31 percent under the tax. In the period after repeal they remained 13 to 24 percent below pre-tax levels — and prices stayed elevated too.
The 27 recommendations cover monitoring, diet and medication for type 1, type 2 and gestational diabetes. WHO had guidance on diabetes and guidance on pregnancy, but never on the two together.
Age-standardised disability-adjusted life-years fell 12.6% since 2010, but the raw total rose 6.1% to 2.80 billion. Anxiety, depression and diabetes rose fastest even after adjusting for ageing.